波士顿市麻省综合医院的K.J.Isselbacher博士及其同事研究成功一种新的血液化验法,用这种方法能在传统的症状出现之前发现难于诊断的癌症,以便早期治疗癌症并增加治愈机会。用血液化验法诊断癌症一直是癌症研究者奋斗的目标。本化验法是以下述发现为基础的,即大多数癌症患者的血液中有一种“半乳糖转移酶同工酶(以下称G T11),而健康人的血液中没有这种物质。 Dr. K.J. Isselbacher and colleagues at the Massachusetts General Hospital in Boston studied the success of a new blood assay that can detect difficult-to-diagnose cancers before the appearance of traditional symptoms, allowing early treatment of cancer and increasing healing opportunities. The use of blood tests to diagnose cancer has been the goal of cancer researchers. This assay is based on the discovery that the majority of cancer patients have a “galactosyltransferase isozyme” (hereinafter referred to as G T11) in the blood, whereas healthy individuals do not have this substance in their blood.